Details about Laura Magazzini

Access statistics for papers by Laura Magazzini.

Last updated 2024-02-07. Update your information in the RePEc Author Service.

Short-id: pma1141

Working Papers

2022

1. Exploring the nexus between appropriability and productivity in highly innovative and globalized companies
   Economics Virtual Symposium 2022, Stata Users Group
2. The Identification of Time-Invariant Variables in Panel Data Model: Exploring the Role of Science in Firms’ Productivity
   IZA Discussion Papers, Institute of Labor Economics (IZA)

2021

3. An LM test for the mean stationarity assumption in dynamic panel-data models
   2021 Stata Conference, Stata Users Group View citations (1)

2019

4. Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach
   IZA Discussion Papers, Institute of Labor Economics (IZA) View citations (1)
   See also Journal Article Exploiting information from singletons in panel data analysis: A GMM approach, Economics Letters, Elsevier (2020) View citations (1) (2020)
5. R&D and market size: who benefits from orphan drug regulation?
   Working Papers, University of Verona, Department of Economics View citations (1)

2018

6. The Joint Estimate of Singleton and Longitudinal Observations: a GMM Approach for Improved Efficiency
   Working Papers, University of Verona, Department of Economics

2014

7. Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo
   Working Papers CERM, Competitività, Regole, Mercati (CERM)
8. Improving GMM efficiency in dynamic models for panel data with mean stationarity
   Working Papers, University of Verona, Department of Economics View citations (1)

2013

9. A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence
   Working Papers, University of Verona, Department of Economics View citations (3)
10. R&D, Within and Between Patent Competition in the Pharmaceutical Industry
    Working Papers, IMT School for Advanced Studies Lucca

2012

11. Identification of linear panel data models when instruments are not available
    Working Papers, University of Verona, Department of Economics
12. The Value of Failures in Pharmaceutical R&D
    Working Papers, IMT School for Advanced Studies Lucca View citations (4)

2011

13. International Cooperation in Pharmaceutical Research
    Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK.
    Also in Working Papers, University of Verona, Department of Economics (2009)
14. Moment Conditions and Neglected Endogeneity in Panel Data Models
    Working Papers, University of Verona, Department of Economics View citations (2)

2010

15. Negative variance estimates in panel data models
    Working Papers, University of Verona, Department of Economics View citations (3)
16. The productivity crisis in pharmaceutical R&D
    Working Papers, University of Verona, Department of Economics View citations (29)

2009

17. A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development
    KITeS Working Papers, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy View citations (41)
    Also in MPRA Paper, University Library of Munich, Germany (2007) View citations (2)
    See also Journal Article A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development, Management Science, INFORMS (2009) View citations (41) (2009)
18. Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood
    Working Papers, University of Verona, Department of Economics
    See also Journal Article Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood, Empirical Economics, Springer (2012) View citations (4) (2012)
19. Nuove politiche per l'innovazione nel settore delle scienze della vita
    Working Papers CERM, Competitività, Regole, Mercati (CERM) View citations (1)
20. Patent Disclosure and R&D Competition in Pharmaceuticals
    DISA Working Papers, Department of Computer and Management Sciences, University of Trento, Italy View citations (8)
    Also in ROCK Working Papers, Department of Computer and Management Sciences, University of Trento, Italy (2009) View citations (9)
    See also Journal Article Patent disclosure and R&D competition in pharmaceuticals, Economics of Innovation and New Technology, Taylor & Francis Journals (2009) View citations (9) (2009)

2008

21. Patent Value and R&D Competition
    Working Papers, University of Verona, Department of Economics
22. The Sustainability of European Health Care Systems: Beyond Income and Ageing
    Working Papers, University of Verona, Department of Economics View citations (3)
    Also in MPRA Paper, University Library of Munich, Germany (2008) View citations (2)
    See also Journal Article The sustainability of European health care systems: beyond income and aging, The European Journal of Health Economics, Springer (2012) View citations (17) (2012)

2007

23. Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico
    Working Papers CERM, Competitività, Regole, Mercati (CERM)
24. La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale
    Working Papers CERM, Competitività, Regole, Mercati (CERM) View citations (4)

2006

25. Everything You Always Wanted to Know about Inventors (But Never Asked): Evidence from the PatVal-EU Survey
    CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations (16)
    Also in LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy (2005) View citations (18)
26. La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica
    Working Papers CERM, Competitività, Regole, Mercati (CERM)

2005

27. Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN
    Working Papers CERM, Competitività, Regole, Mercati (CERM)
28. Medical Devices Competitiveness and Impact on Public Health Expenditure
    MPRA Paper, University Library of Munich, Germany View citations (17)
    Also in Working Papers CERM, Competitività, Regole, Mercati (CERM) (2005) View citations (18)

2004

29. Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure
    MPRA Paper, University Library of Munich, Germany View citations (21)

2003

30. Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato
    Working Papers CERM, Competitività, Regole, Mercati (CERM)

2001

31. Simulation-based estimation of Tobit model with random effects
    MPRA Paper, University Library of Munich, Germany View citations (5)

Journal Articles

2023

1. A Lagrange multiplier test for the mean stationarity assumption in dynamic panel-data models
   Stata Journal, 2023, 23, (2), 418-437 View citations (1)
2. Assessing individual skill influence on housework time of Italian women: an endogenous-switching approach
   Statistical Methods & Applications, 2023, 32, (2), 659-679

2021

3. Maximum likelihood estimation of an across-regime correlation parameter
   Stata Journal, 2021, 21, (2), 430-461 View citations (1)
4. R&D and market size: Who benefits from orphan drug legislation?
   Journal of Health Economics, 2021, 80, (C) View citations (3)

2020

5. Exploiting information from singletons in panel data analysis: A GMM approach
   Economics Letters, 2020, 186, (C) View citations (1)
   See also Working Paper Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach, IZA Discussion Papers (2019) View citations (1) (2019)
6. Testing initial conditions in dynamic panel data models
   Econometric Reviews, 2020, 39, (2), 115-134 View citations (2)
   Also in Econometric Reviews, 2019, 39, (2), 115-134 (2019)
7. Using information from singletons in fixed-effects estimation: xtfesing
   Stata Journal, 2020, 20, (4), 965-975

2019

8. Does regulation drive international research cooperation? Evidence from the pharmaceutical sector
   The World Economy, 2019, 42, (4), 1200-1223

2016

9. Learning from successes and failures in pharmaceutical R&D
   Journal of Evolutionary Economics, 2016, 26, (2), 271-290 View citations (5)

2013

10. Resale Price Maintenance: An Empirical Analysis of UK Firms' Compliance
    Economic Journal, 2013, 123, (11), F582-F595 View citations (1)

2012

11. Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood
    Empirical Economics, 2012, 43, (1), 145-152 View citations (4)
    See also Working Paper Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood, Working Papers (2009) (2009)
12. The sustainability of European health care systems: beyond income and aging
    The European Journal of Health Economics, 2012, 13, (5), 623-634 View citations (17)
    See also Working Paper The Sustainability of European Health Care Systems: Beyond Income and Ageing, Working Papers (2008) View citations (3) (2008)

2009

13. A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development
    Management Science, 2009, 55, (10), 1638-1653 View citations (41)
    See also Working Paper A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development, KITeS Working Papers (2009) View citations (41) (2009)
14. Patent disclosure and R&D competition in pharmaceuticals
    Economics of Innovation and New Technology, 2009, 18, (5), 467-486 View citations (9)
    See also Working Paper Patent Disclosure and R&D Competition in Pharmaceuticals, DISA Working Papers (2009) View citations (8) (2009)

2007

15. Inventors and invention processes in Europe: Results from the PatVal-EU survey
    Research Policy, 2007, 36, (8), 1107-1127 View citations (134)

2004

16. Dynamic competition in pharmaceuticals
    The European Journal of Health Economics, 2004, 5, (2), 175-182 View citations (24)

2002

17. The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis
    Revue d'Économie Industrielle, 2002, 99, (1), 107-131 View citations (12)

Chapters

2023

1. Linear Dynamic Panel Data Models: Exploring the Patent-R&D Relationship in Europe
   Springer